Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dipexium Pharmaceuticals Inc (NASDAQ:DPRX)

16.70
Delayed Data
As of Jul 31
 +0.31 / +1.89%
Today’s Change
8.50
Today|||52-Week Range
17.10
+46.68%
Year-to-Date

Today’s Trading

Previous close16.39
Today’s open16.54
Day’s range16.32 - 16.78
Volume19,276
Average volume (3 months)27,421
Market cap$168.1M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-98.85%
Earnings growth (this year)-6.07%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.50

Competitors

 Today’s
change
Today’s
% change
FBIOFortress Biotech Inc-0.09-2.60%
EPRSEPIRUS Biopharmaceut...+0.22+3.51%
GTXIGTX Inc+0.02+1.83%
SMMTSummit Therapeutics ...+0.12+0.94%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$0.00
Annual profit (last year)-$13.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
David P. Luci
Vice President-Finance &
Corporate Development
David Garrett
Corporate headquarters
New York, New York

Forecasts